Eli Lilly Co and privately-held AbCellera Biologics Inc on Thursday
announced they would co-develop antibody products for the treatment of
COVID-19, a flu-like disease caused by the fast-spreading coronavirus.
AbCellera and Lilly have committed to equally share initial development costs towards a product, the companies said.
Lilly will be responsible for all further development, manufacturing and distribution.
https://www.reuters.com/article/us-health-coronavirus-lilly/eli-lilly-abcellera-biologics-to-co-develop-coronavirus-therapies-idUSKBN20Z3QC
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.